Compare CPB & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CPB | TFX |
|---|---|---|
| Founded | 1869 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 5.3B |
| IPO Year | 1994 | 1994 |
| Metric | CPB | TFX |
|---|---|---|
| Price | $22.88 | $132.15 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 18 | 8 |
| Target Price | $26.06 | ★ $138.75 |
| AVG Volume (30 Days) | ★ 8.2M | 616.7K |
| Earning Date | 06-01-2026 | 05-07-2026 |
| Dividend Yield | ★ 7.63% | 1.02% |
| EPS Growth | ★ 6.35 | N/A |
| EPS | ★ 1.55 | N/A |
| Revenue | ★ $10,253,000,000.00 | $1,992,713,000.00 |
| Revenue This Year | N/A | $15.97 |
| Revenue Next Year | $0.11 | $5.15 |
| P/E Ratio | $14.28 | ★ N/A |
| Revenue Growth | ★ 6.40 | N/A |
| 52 Week Low | $19.56 | $100.18 |
| 52 Week High | $34.18 | $139.67 |
| Indicator | CPB | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 74.22 | 54.44 |
| Support Level | $19.78 | $124.15 |
| Resistance Level | $31.86 | $134.98 |
| Average True Range (ATR) | 0.77 | 3.39 |
| MACD | 0.26 | 0.13 |
| Stochastic Oscillator | 95.79 | 66.12 |
Over the past 150-plus years, Campbell's has evolved into a leading domestic packaged food manufacturer, with a portfolio that extends beyond its iconic red-and-white labeled canned soup. In fiscal 2025 (July year-end), snacks accounted for 43% of its revenue, followed by soup (27%), other simple meals (23%), and beverages (7%). Beyond its namesake, its brands include Pepperidge Farm, Goldfish, Snyder's of Hanover, Swanson, Pacific Foods, Prego, Pace, V8, and, most recently, Rao's (a deal that closed in 2024). Around 90% of its revenue results from the US and the remainder from Canada and Latin America.
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.